Sign In
Buy DXCM
$72.77
-0.680 (-0.93%)
At Close: Jun 03, 2026
DexCom (DXCM) Reports Q4 Earnings: What Key Metrics Have to Say
06:31pm, Thursday, 08'th Feb 2024
The headline numbers for DexCom (DXCM) give insight into how the company performed in the quarter ended December 2023, but it may be worthwhile to compare some of its key metrics to Wall Street estima
Dexcom beats profit estimates on strong demand for glucose monitors
05:10pm, Thursday, 08'th Feb 2024
Glucose monitor maker Dexcom beat analyst estimates for fourth-quarter earnings on Thursday, helped by strong demand for its continuous glucose monitoring (CGM) systems.
DexCom (DXCM) Launches One+ Real-time CGM System in Europe
10:35am, Thursday, 08'th Feb 2024
DexCom (DXCM) unveils its new CGM system, Dexcom ONE+, which is set to provide easy and effective care to diabetic patients.
3 Nasdaq stocks likely to make big earnings splashes
07:14am, Wednesday, 07'th Feb 2024
The widely followed Nasdaq-100 index is up 13 of the last 14 weeks, a huge move that dates back to Halloween. Booming artificial intelligence plays and hopes of multiple Fed rate cuts this year have p
DexCom (DXCM) to Report Q4 Earnings: Is a Beat in Store?
09:56am, Monday, 05'th Feb 2024
DexCom's (DXCM) fourth-quarter 2023 results are likely to reflect rising volumes across all channels.
DexCom (DXCM) Increases Despite Market Slip: Here's What You Need to Know
06:56pm, Wednesday, 31'st Jan 2024
In the closing of the recent trading day, DexCom (DXCM) stood at $121.35, denoting a +0.46% change from the preceding trading day.
Why DexCom (DXCM) is a Top Growth Stock for the Long-Term
10:46am, Thursday, 25'th Jan 2024
Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.
DexCom (DXCM) Stock Declines While Market Improves: Some Information for Investors
07:06pm, Tuesday, 23'rd Jan 2024
DexCom (DXCM) concluded the recent trading session at $127.12, signifying a -1.68% move from its prior day's close.
These 2 Growth Stocks Are Brilliant Buys for the New Year
09:45am, Tuesday, 23'rd Jan 2024
The healthcare industry has long been a compelling space for investors to generate steady returns. DexCom is raking in profits from newly launched products, and its long-term growth story looks bright
Dexcom (DXCM) Set to Solidify Its Business Throughout EMEA
11:36am, Monday, 22'nd Jan 2024
Dexcom (DXCM), opening a new manufacturing facility in the West of Ireland, is expected to boost production of rtCGM sensors and create employment.
Reasons to Retain DexCom (DXCM) Stock in Your Portfolio for Now
10:36am, Friday, 19'th Jan 2024
DexCom (DXCM) continues to raise optimism among investors, owing to its strong product portfolio.
DexCom (DXCM) Advances While Market Declines: Some Information for Investors
07:06pm, Wednesday, 17'th Jan 2024
DexCom (DXCM) closed the most recent trading day at $125.45, moving +0.8% from the previous trading session.
Why DexCom (DXCM) Could Beat Earnings Estimates Again
01:11pm, Wednesday, 17'th Jan 2024
DexCom (DXCM) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.
3 Mid-Cap Stocks Poised for a Breakout in 2024
06:10pm, Tuesday, 16'th Jan 2024
Important voices in the investment world predict that 2024 could be a very strong year for mid-cap stocks. Janus Henderson portfolio manager Brian Demain believes the outlook for mid caps looks favora
Charts turn bullish on health-care stocks as sector takes early lead in 2024
11:29am, Tuesday, 16'th Jan 2024
Chart-watchers are growing increasingly bullish on health-care stocks now that they have become the best-performing sector of the S&P 500 so far in 2024, according to Dow Jones Market Data. Analysts h
